Crohn’s Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab is a research paper published in Inflammatory Bowel Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1R01DK131005
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: SDDRC P30
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: DK126626
Institutional Research and Career Development
Grant: K12, K12GM068524
NIDDK NIH HHS
Grant: R01 DK131005
NIGMS NIH HHS
Grant: K12 GM068524
NIDDK NIH HHS
Grant: U34 DK126626
National Institute of Health
Research Council at the KU Leuven
University Hospitals Leuven
Clinical Research Fund
MeSH Terms
Keywords